medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2002, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2002; 1 (3)


Hepatitis C and liver transplantation

Moreno R, Berenguer M

Idioma: Ingles.
Referencias bibliográficas: 49
Paginas: 129-135
Archivo PDF: 63.36 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. European Liver Transplant Registry: www.eltr.org

  2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Sem Liv Dis 2000; 20: 1-16.

  3. Fattovitch G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-72.

  4. Shiratori Y, Shiina S, Teratani T, et al. Combination of tumor ablation and interferon therapy remarkably improves prognosis and liver function in hepatitis C viral-hepatocellular carcinoma. Hepatology 2000; 32: 206A.

  5. Pereira BJ, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484-7.

  6. Testa G, Goldstein RM, Netto G, et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 1998; 65: 925-9.

  7. Vargas HE, Laskus T, Wang LF, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999; 117: 149-53.

  8. Wright TL, Donegan E, Hsu H et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-22.

  9. Chazouilleres O, Kim M, Combs C et al. Quantitation of Hepatitis C Virus RNA in Liver Transplant Recipients. Gastroenterology 1994; 106: 994-9.

  10. Pelletier SJ, Raymond DP, Crabtree TD, et al. Hepatitis C-induced hepatic allograft injury is associated with a pre-transplantation elevated viral replication rate. Hepatology 2000; 32: 418-426.

  11. Prieto M, Berenguer M, Rimola A, et al. Liver Transplantation in hepatitis C: a Spanish multicenter experience. Eur J Gastroenterol Hepatol 1998; 10: 771-776

  12. Gane E, Portmann B, Naoumov N, et al. Long-Term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815-820.

  13. Prieto M, Berenguer M, Rayón M, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29:250-256 .

  14. Feray C, Caccamo L, Alexander GJM, et al. European Collaborative Study on factors influencing the outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117: 619-25.

  15. Testa G, Crippin JS, Netto GJ, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553-561.

  16. Sanchez-Fueyos A, Restrepo J-C, Quintó Llorenc, et al. Impact of the recurrence of hepatitis C infection after liver transplantation on the long term viability of the graft. Transplantation 2002; 73: 56-63.

  17. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673-684.

  18. Berenguer M, Rayón M, Prieto M, et al. Are post-transplantation protocol liver biopsies useful in the long-term? Liver transplantation 2001;7: 790-6.

  19. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202-210.

  20. Berenguer M, Prieto M, Rayón JM, et al. Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation. Hepatology 2000; 32: 852-8.

  21. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.

  22. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and Liver transplantation. J Hepatol 2001; 35: 666-678.

  23. Gigou M, Roque-Alfonso AM, Falissard B, et al. Genetic clustering of hepatitis C virus strains and severity of recurrent hepatitis after liver transplantation. J Virol 2001; 75: 11292-7.

  24. Schluger L, Sheiner P, Thung S, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-976.

  25. DiMartino V, Saurini F, Samuel D, et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997; 26: 1343-1350.

  26. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823-30

  27. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32: 1125-30.

  28. Rosen HR, Hinrichs DJ, Gretch DR, et al. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999; 117: 926-32.

  29. Jain A, Kashyap R, Demetris AJ, Eghstesad B, Pokharna R, Fung JJ. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl 2002; 8(1): 40-6.

  30. Nelson DR, Soldevila-Pico C, Reed A, et al. The effect of anti-interleukin-2 receptor therapy on the course of hepatitis C recurrence after liver transplantation. Liver Transpl 2001; 7: 1064-1070.

  31. Brillanti S, et al. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl (in press).

  32. Crippin JS, Sheiner P, Terrault NA, et al. A pilot study of the tolerability and efficacy of antiviral therapy in patients awaiting liver transplantation for hepatitis C. Liver Transplantation 2002; 8: 350-355.

  33. Everson GT, Trouillot T, Trotter J, et al. Treatment of decompensated cirrhotics with a slow-accelearting dose regimen (LADR) of interferon-alfa-2b plus ribavirin: safety and efficacy. Hepatology 2000; 32: 308A.

  34. Sheiner P, Boros P, Klion FM, et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28: 831-38.

  35. Singh N, Gayowski T, Wannstedt C, et al. Interferon-a for prophylaxis of recurrent viral hepatitis C in liver transplant recipients. Transplantation 1998; 65: 82-86.

  36. Mazzaferro V, Tagger A, Schiavo M, Regalia E, Pulvirenti A, Ribero ML, et al. Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transpl Proc 2001; 33: 1355-1357.

  37. Wright TL, Combs C, Kim M, et al. Interferon alpha therapy for hepatitis C virus infection following liver transplantation. Hepatology 1994; 20: 773-9.

  38. Feray C, Samuel D, Gigou M, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-1089.

  39. Gane EJ, Lo SK, Riordan SM, et al. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27: 1403-07.

  40. Bizollon T, Palazzo U, Ducerf C, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997: 26: 500-504.

  41. Alberti AB, Belli LS, Airoldi A, et al. Combined therapy with interferon and low-dose ribavirin in post-transplantation recurrent hepatitis C: a pragmatic study. Liver Transpl 2001; 7(10): 870-6.

  42. Gopal DV, Rabkin JM, Berk BS, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001; 7(3): 181-90.

  43. Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO. Recurrent hepatitis C after liver transplantation: a non randomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 2001; 7(10): 863-9.

  44. De Vera ME, Smallwood GA, Rosado K, et al. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis Cafter liver transplantation. Transplantation 2001; 71(5): 678-86.

  45. Narayanan M, Poterucha JJ, El-Amin OM, et al. Treatment of post-transplantation recurrence of hepatitis C wih interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl 2002; 8: 623-9.

  46. Bizollon T, Ducerf C, Chevallier M, et al. Long-term efficacy of ribavirin plus IFN in the treatment of HCV recurrence after liver transplantation. 11th Congress of the European Society for Organ Transplantation. Oslo 1999, June 19-24 (Abst 20).

  47. Sheiner PA, Schluger LK, Emre S, et al. Retransplantation for recurrent hepatitis C. Liver Transpl Surg 1997; 3: 130-6.

  48. Rosen H, O’Reilly P, Shackleton C, et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1997; 62: 1773-1776.

  49. Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology 1999; 29: 365-70.




2020     |     www.medigraphic.com